Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
Pasireotide G2304 Study Group, for the, Pasireotide G2304 Study Group
科研成果: 期刊稿件 › 文章 › 同行评审
125
引用
（Scopus）